Asosiy kontentga oʻtish
Maqola

Tau activation of microglial cGAS–IFN reduces MEF2C-mediated cognitive resilience

Joe C. UdeochuMIND Research InstituteSadaf AminWeill Cornell MedicineYige HuangHelen and Robert Appel Alzheimer's Disease Research Institute, Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USALi FanHelen and Robert Appel Alzheimer's Disease Research Institute, Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USAEileen Ruth S. TorresWeill Cornell MedicineGillian CarlingMIND Research InstituteBangyan LiuHelen and Robert Appel Alzheimer's Disease Research Institute, Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USAHugo McGurranThe Gladstone Institute of Neurological Disease, San Francisco, CA, USAGuillermo Coronas‐SamanoHelen and Robert Appel Alzheimer's Disease Research Institute, Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USAGrant KauweBuck Institute for Research on Aging, Novato, CA, USAGergey Alzaem MousaWeill Cornell MedicineMan Ying WongMIND Research InstitutePearly YeMIND Research InstituteNagiri Ravi KumarWeill Cornell MedicineIris LoThe Gladstone Institute of Neurological Disease, San Francisco, CA, USAJulia HoltzmanThe Gladstone Institute of Neurological Disease, San Francisco, CA, USACarlo CoronaBurke Medical Research InstituteAllan YarahmadyDepartment of Biochemistry, University of Alberta, Edmonton, Alberta, CanadaMichael GillThe Gladstone Institute of Neurological Disease, San Francisco, CA, USARavikiran M. RajuDivision of Newborn Medicine, Boston Children's Hospital, Boston, MA, USASue‐Ann MokDepartment of Biochemistry, University of Alberta, Edmonton, Alberta, CanadaShiaoching GongMIND Research InstituteWenjie LuoMIND Research InstituteMingrui ZhaoMIND Research InstituteTara E. TracyBuck Institute for Research on Aging, Novato, CA, USARajiv R. RatanBurke Medical Research InstituteLi‐Huei TsaiThe Picower Institute of Learning and Memory, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USASubhash C. SinhaMIND Research InstituteLi GanWeill Cornell Medicine
2023en
ABI

Annotatsiya

Pathological hallmarks of Alzheimer's disease (AD) precede clinical symptoms by years, indicating a period of cognitive resilience before the onset of dementia. Here, we report that activation of cyclic GMP-AMP synthase (cGAS) diminishes cognitive resilience by decreasing the neuronal transcriptional network of myocyte enhancer factor 2c (MEF2C) through type I interferon (IFN-I) signaling. Pathogenic tau activates cGAS and IFN-I responses in microglia, in part mediated by cytosolic leakage of mitochondrial DNA. Genetic ablation of Cgas in mice with tauopathy diminished the microglial IFN-I response, preserved synapse integrity and plasticity and protected against cognitive impairment without affecting the pathogenic tau load. cGAS ablation increased, while activation of IFN-I decreased, the neuronal MEF2C expression network linked to cognitive resilience in AD. Pharmacological inhibition of cGAS in mice with tauopathy enhanced the neuronal MEF2C transcriptional network and restored synaptic integrity, plasticity and memory, supporting the therapeutic potential of targeting the cGAS-IFN-MEF2C axis to improve resilience against AD-related pathological insults.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar

2 ta iqtibos0 ta foydalanilgan manba